Study of metastatic kinetics in metastatic melanoma treated with B-RAF inhibitors: Introducing mathematical modelling of kinetics into the therapeutic decision

BACKGROUND: Evolution of metastatic melanoma (MM) under B-RAF inhibitors (BRAFi) is unpredictable, but anticipation is crucial for therapeutic decision. Kinetics changes in metastatic growth are driven by molecular and immune events, and thus we hypothesized that they convey relevant information for...

Descripción completa

Detalles Bibliográficos
Autores principales: Hartung, Niklas, Huynh, Cécilia T.-K., Gaudy-Marqueste, Caroline, Flavian, Antonin, Malissen, Nausicaa, Richard-Lallemand, Marie-Aleth, Hubert, Florence, Grob, Jean-Jacques
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5417482/
https://www.ncbi.nlm.nih.gov/pubmed/28472075
http://dx.doi.org/10.1371/journal.pone.0176080

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5417482/
https://www.ncbi.nlm.nih.gov/pubmed/28472075
http://dx.doi.org/10.1371/journal.pone.0176080

Ejemplares similares